News

Find News

Filter articles

Showing 111 to 120 of 3276 results

Judge rejects Allergan challenge to FCA suit

US15-12-2020Sarah Morgan

A California judge has allowed a patent attorney to proceed with his claims against Allergan which allege the pharmaceutical company fraudulently obtained patents to monopolise pricing.

AstraZeneca to buy Alexion for $39bn

UK, US14-12-2020Sarah Morgan

AstraZeneca has announced it will acquire Boston-based biopharmaceutical company Alexion Pharmaceuticals, in what is potentially the biggest life sciences deal of this year. 

Amgen faces struggle to revive cholesterol patents, says Fed Circ judge

US14-12-2020Muireann Bolger

Amgen is unlikely to succeed in its bid to revive its patents for the cholesterol drug Repatha, a judge at the US Court of Appeals for the Federal Circuit has told the pharmaceutical company.

90% of essential medicines off-patent, study reveals

International10-12-2020Muireann Bolger

Only 10% of essential medicines recommended by the World Health Organisation are on patent, according to a report by research and advocacy organisation, the Geneva Network.

Tris blocks Actavis’ ADHD generic

US10-12-2020Rory O'Neill

New Jersey-based Tris Pharma has won a ruling blocking Teva-owned Actavis from launching a generic version of attention deficit and hyperactivity disorder drug Quillivant XR.

Haier division scores win in global patent dispute

UK10-12-2020Rory O'Neill

Flexicare infringed a breathing tube patent owned by New Zealand appliance maker Fisher & Paykel (F&P), the English High Court has ruled.

Danish university sues Creative Biolabs over ‘antibody pirating’

Denmark, US09-12-2020Sarah Morgan

The University of Southern Denmark has accused biotech Creative Biolabs of infringing its patent-protected monoclonal antibody, HG-HYB 7-5. 

Neurim prevails against Mylan in suit over insomnia drug

US08-12-2020Muireann Bolger

Neurim Pharmaceuticals has won its case against generics drug maker Mylan at the English High Court, which held that its patent for a treatment for insomnia was valid and had been infringed in a ruling handed down on December 4.

Number of pay-for-delay deals remains low, says FTC

US07-12-2020Sarah Morgan

The number of potentially anticompetitive patent infringement settlements between brand drugmakers and generic competitors remained low in 2017, according to the Federal Trade Commission.

Illumina, Roche accused of infringing genetic testing patents

US07-12-2020Muireann Bolger

Pharmaceutical companies Illumina and Roche have been sued for allegedly infringing two patents covering the technology for non-invasive DNA testing by Maryland genetic testing company Ravgen.

Showing 111 to 120 of 3276 results

LSIPR